IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

PDL Biopharma Inc (PDLI)

CUSIP: 69329Y104 | 590 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13GBrandes Investment Partners, LP7,024,1026.2%New 5%+ stakeJun 30, 20264,723,376 sh (Sep 30, 2020)
13GBrandes Investment Partners, LP7,024,102
6.2% of class · Jun 30, 2026New 5%+ stake
4,723,376 sh (Sep 30, 2020)

Institutional Holders — Q3 2026

Westside Investment Management, Inc.500
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Westside Investment Management, Inc.
500$00.0%GrowthLowSanta Monica, CA2026-11-02